Current Report Filing (8-k)
16 May 2017 - 10:46PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported):
May 15, 2017
MEDICAL
TRANSCRIPTION BILLING, CORP.
(Exact name of registrant as specified in its charter)
Delaware
|
|
333-192989
|
|
22-3832302
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
7
Clyde Road, Somerset, New Jersey, 08873
(Address of principal executive offices, zip code)
(732)
873-5133
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [x]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [x]
On
May 15, 2017, the Company closed on the registered direct offering which was previously announced in a Form 8-K filed by the Company
on May 10, 2017.
The
Company also issued a press release regarding the closing described above under this Current Report on Form 8-K. A copy of the
press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The
information in this Item 8.01 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed
“filed” for purposes of Section 18 of the United States Securities Exchange Act of 1934 (the “Exchange Act”)
or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under
the United States Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in
such a filing.
Item
9.01
|
Financial
Statements and Exhibits:
|
|
99.1
|
Press
Release, dated May 16, 2017.
|
SIGNATURE(S)
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
|
Medical
Transcription Billing, Corp.
|
|
|
|
|
By:
|
/s/
Mahmud Haq
|
Date:
May 16, 2017
|
|
Mahmud
Haq
Chairman
of the Board and Chief Executive Officer
|
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Sep 2024 to Oct 2024
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about CareCloud Inc (NASDAQ): 0 recent articles
More Medical Transcription Billing, Corp News Articles